UPF0761 membrane protein XOO3615 is a bacterial protein derived from Xanthomonas oryzae pv. oryzae, a significant plant pathogen that causes bacterial blight in rice. The protein is classified as part of the UPF0761 family, with "UPF" designation indicating an uncharacterized protein family with conserved sequences across various bacterial species. This recombinant protein has been produced to facilitate research into bacterial membrane proteins and potentially to understand the pathogenicity mechanisms of Xanthomonas oryzae.
The protein is cataloged in the UniProt database with the accession number Q5GWQ2, providing standardized identification for research purposes. As a membrane protein, XOO3615 is embedded within the bacterial cell membrane, suggesting potential roles in cellular processes such as transport, signaling, or maintaining membrane integrity in the bacterial host organism.
The recombinant version of XOO3615 exhibits several key physical and biochemical properties that are relevant for research applications. These properties are summarized in the following table:
| Property | Description |
|---|---|
| Organism Source | Xanthomonas oryzae pv. oryzae |
| UniProt ID | Q5GWQ2 |
| Protein Length | 425 amino acids (Full Length) |
| Molecular Function | Membrane protein (specific function uncharacterized) |
| Physical Form | Lyophilized powder (recombinant) |
| Purity | Greater than 90% as determined by SDS-PAGE |
The recombinant protein's high purity level makes it suitable for a variety of research applications, including structural studies, functional assays, and the development of targeted inhibitors.
The recombinant UPF0761 membrane protein XOO3615 is produced using Escherichia coli as an expression system. This approach leverages E. coli's efficient protein synthesis machinery to generate substantial quantities of the target protein for research applications. The use of bacterial expression systems is particularly advantageous for producing bacterial proteins, as it often results in correct folding and post-translational modifications.
The recombinant UPF0761 membrane protein XOO3615 is typically produced with an N-terminal histidine (His) tag. This modification involves adding a sequence of histidine residues to the N-terminus of the protein, which serves several important purposes:
Facilitates purification through affinity chromatography using metal chelate resins
Enables detection of the protein using anti-His antibodies
May assist in solubility and stability of the recombinant protein
The addition of the His tag results in a fusion protein that maintains the functional domains of the native XOO3615 while providing technical advantages for laboratory handling and applications.
The lyophilized recombinant protein requires proper reconstitution to ensure optimal activity for experimental applications. The recommended reconstitution protocol includes:
Brief centrifugation of the vial prior to opening to bring contents to the bottom
Reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Addition of glycerol to a final concentration of 5-50% (typically 50% is recommended)
Aliquoting for long-term storage at -20°C to -80°C
This approach minimizes protein degradation while providing convenient working stocks for experimental use. The addition of glycerol prevents ice crystal formation during freezing, which can damage protein structure.
The UPF0761 family includes membrane proteins from various bacterial species. One notable related protein is the UPF0761 membrane protein Patl_3954 from Pseudoalteromonas atlantica. Comparing these proteins provides evolutionary and functional context for understanding XOO3615.
| Feature | XOO3615 (Xanthomonas oryzae) | Patl_3954 (Pseudoalteromonas atlantica) |
|---|---|---|
| UniProt ID | Q5GWQ2 | Q15NT4 |
| Length | 425 amino acids | 300 amino acids |
| Expression System | E. coli | E. coli |
| Tag | N-terminal His | N-terminal His |
| Organism Type | Plant pathogen (rice) | Marine bacterium |
Despite belonging to the same protein family, these proteins differ significantly in length and originate from bacteria with different ecological niches, suggesting potential functional adaptations specific to their respective environments.
The recombinant UPF0761 membrane protein XOO3615 serves as a valuable tool for various research applications:
Structural studies to elucidate the three-dimensional conformation using techniques such as X-ray crystallography or cryo-electron microscopy
Functional assays to investigate potential roles in transport, signaling, or membrane integrity
Development of antibodies for detection and localization studies
Protein-protein interaction studies to identify binding partners
Comparative analyses with homologous proteins from other bacterial species
As a purified recombinant protein, XOO3615 enables controlled in vitro studies that would be challenging with the native protein in its cellular context.
Modern computational approaches represent powerful tools for predicting protein function from sequence data. Methods such as deep learning networks for protein functional inference, as described in the ProteInfer approach, could potentially provide insights into XOO3615 function by:
Identifying structural similarities to proteins of known function
Predicting functional domains and motifs
Analyzing genomic context and co-expression patterns
Mapping potential interaction networks
These computational predictions can generate testable hypotheses about the protein's biological role in Xanthomonas oryzae.
Understanding the structure and function of UPF0761 membrane protein XOO3615 presents several promising avenues for future research:
Detailed structural determination using advanced biophysical techniques to elucidate the three-dimensional conformation
Functional characterization through biochemical assays, mutagenesis studies, and in vivo experiments
Investigation of potential roles in bacterial pathogenicity, particularly in the context of rice bacterial blight
Development of targeted inhibitors that could have agricultural applications for controlling Xanthomonas infections
Comparative functional studies with homologous proteins from other bacterial species
These research directions could significantly advance our understanding of this uncharacterized protein family and potentially reveal new targets for agricultural disease management strategies.
KEGG: xoo:XOO3615
UPF0761 membrane protein XOO3615 is a membrane protein found in Xanthomonas oryzae pv. oryzae, a gram-negative bacterium that causes bacterial leaf blight in rice plants. The "UPF" designation indicates it belongs to an uncharacterized protein family (UPF0761), suggesting its function is not yet fully characterized. This protein is also referred to by the gene name "rbn" in some contexts and is sometimes labeled as a "hypothetical protein" . The protein is integral to the bacterial membrane and may play roles in essential cellular processes, though specific functions remain to be fully elucidated.
Recombinant UPF0761 membrane protein XOO3615 can be produced using various expression systems including cell-free expression systems and heterologous hosts such as E. coli, yeast, baculovirus, or mammalian cell systems . For membrane proteins, which can be challenging to express properly, the choice of expression system is critical. Cell-free expression systems offer advantages for initial studies as they can handle hydrophobic domains efficiently. For larger-scale production, E. coli or yeast systems may be preferable, while mammalian expression systems might be necessary if specific post-translational modifications are required for function . Each system presents distinct advantages and limitations that should be evaluated based on research objectives.
Recombinant UPF0761 membrane protein XOO3615 requires specific storage conditions to maintain stability and functionality. The protein is typically stored in a Tris-based buffer containing 50% glycerol, which helps prevent protein denaturation during freeze-thaw cycles . For short-term use (up to one week), the protein can be stored at 4°C. For longer-term storage, temperatures of -20°C or preferably -80°C are recommended . It's important to note that repeated freezing and thawing should be avoided as this can lead to protein degradation and loss of activity. Researchers should prepare working aliquots to minimize freeze-thaw cycles and maintain protein integrity.
Studying the function of an uncharacterized membrane protein like UPF0761 membrane protein XOO3615 requires a comprehensive experimental design strategy. Optimal experimental designs allow parameters to be estimated without bias and with minimum variance, thereby reducing the costs of experimentation . A methodical approach would include:
Sequential Analysis Strategy:
Response-Surface Methodology:
Experimental Variables Matrix:
| Parameter | Levels to Test | Measurement Method |
|---|---|---|
| pH | 5.5, 6.5, 7.5, 8.5 | Activity assays |
| Temperature | 25°C, 30°C, 37°C, 42°C | Thermal stability |
| Ionic strength | 50mM, 100mM, 200mM, 300mM | Binding affinity |
| Ligands | Control, Candidate 1-3 | Interaction studies |
Control Integration:
Include positive controls (well-characterized membrane proteins)
Incorporate negative controls (denatured protein, empty vector)
Design proper replication to account for experimental variance
This approach minimizes the number of experiments needed while maximizing information gained, creating an efficient path to functional characterization .
Identifying interaction partners of membrane proteins like UPF0761 XOO3615 presents unique challenges requiring specialized approaches:
In Vivo Crosslinking Strategies:
Photo-crosslinking with genetically incorporated unnatural amino acids
Chemical crosslinking with membrane-permeable reagents
Analysis of crosslinked complexes by mass spectrometry
Proximity-Based Labeling Methods:
BioID: Fusion with promiscuous biotin ligase BirA*
APEX2: Fusion with engineered ascorbate peroxidase
TurboID: Enhanced biotin ligase for faster labeling
Quantitative analysis of labeled proteins by mass spectrometry
Membrane-Specific Yeast Two-Hybrid Systems:
Split-ubiquitin membrane yeast two-hybrid
MYTH (Membrane Yeast Two-Hybrid)
Careful design of bait constructs to maintain membrane topology
Co-Purification Approaches:
Optimization of detergent conditions to preserve interactions
Use of covalent crosslinking prior to solubilization
Application of gentle extraction methods like SMALPs
Validation Matrix:
| Method | Strengths | Limitations | Validation Approach |
|---|---|---|---|
| Crosslinking | Captures transient interactions | Potential artifacts | Reverse crosslinking |
| Proximity labeling | Works in native environment | Non-specific labeling | Distance-dependent controls |
| Co-purification | Direct physical interaction | Detergent interference | Reciprocal pulldowns |
| Genetic methods | Functional relevance | Indirect interactions | Phenotypic validation |
By employing multiple complementary approaches and validating findings through independent methods, researchers can build a high-confidence interaction network for UPF0761 membrane protein XOO3615.
Optimizing solubilization and purification of UPF0761 membrane protein XOO3615 for structural studies requires a systematic approach addressing the unique challenges of membrane proteins:
Detergent Screening Strategy:
Begin with mild detergents (DDM, LMNG) that maintain protein folding
Test detergent mixtures for improved extraction efficiency
Consider newer solubilization systems like nanodiscs, SMALPs, or amphipols
Monitor protein quality after solubilization by size-exclusion chromatography
Buffer Optimization Framework:
Implement optimal experimental design principles to efficiently test multiple variables
Create a factorial design testing pH, salt concentration, and additives simultaneously
Include stabilizing agents like glycerol or specific lipids
Use thermal stability assays to quantitatively assess buffer improvements
Purification Protocol Optimization:
Employ two-step or three-step purification strategies
Consider on-column detergent exchange during affinity purification
Optimize elution conditions to maintain protein stability
Use size exclusion chromatography as a final polishing step and quality control
Stability Assessment Techniques:
Differential scanning fluorimetry to assess thermal stability
Size exclusion chromatography to monitor monodispersity
Activity assays (if available) to confirm functional integrity
Limited proteolysis to identify stable domains
Applying EMC-Inspired Approaches:
This methodical approach maximizes the likelihood of obtaining stable, homogeneous protein suitable for high-resolution structural studies while minimizing sample consumption.
Predicting functional sites in uncharacterized membrane proteins like UPF0761 XOO3615 requires sophisticated computational approaches:
Evolutionary Analysis Methods:
Multiple sequence alignment of UPF0761 family members
Calculation of conservation scores to identify highly conserved residues
Correlation-based methods to detect co-evolving residue networks
Evolutionary trace analysis to map conservation onto structural models
Structure-Based Prediction Tools:
Machine Learning Approaches:
Trained neural networks for functional site prediction
Feature extraction from sequence and structural data
Integration of diverse data sources through ensemble methods
Confidence scoring for predictions based on model validation
Molecular Dynamics Simulations:
Identification of conformationally flexible regions
Water and ion accessibility analysis
Lipid interaction sites mapping
Binding site flexibility assessment
Integrative Prediction Framework:
| Prediction Method | Output Data | Validation Approach |
|---|---|---|
| Conservation analysis | Conserved residue clusters | Comparison with related characterized proteins |
| Cavity detection | Potential binding pockets | Ligand docking simulations |
| Electrostatic mapping | Charged interaction sites | Comparison with known membrane transport mechanisms |
| MD simulations | Dynamic functional regions | Correlation with predicted topology |
These computational predictions should guide subsequent experimental verification through site-directed mutagenesis, providing a rational approach to functional characterization of this uncharacterized membrane protein.
Investigating the potential role of UPF0761 membrane protein XOO3615 in Xanthomonas oryzae pathogenicity requires a comprehensive experimental design:
Gene Knockout/Modification Strategy:
Generate clean deletion mutants using allelic exchange
Create conditional expression strains if the gene is essential
Develop complementation constructs with wild-type and mutant variants
Design constructs for site-directed mutagenesis of predicted functional sites
Virulence Phenotyping Framework:
Quantitative pathogenicity assays in rice plants
Measurement of bacterial growth kinetics in planta
Analysis of symptom development and progression
Comparative analysis across multiple rice cultivars
Molecular Mechanism Investigation:
Transcriptome analysis of wild-type vs. mutant bacteria during infection
Secretome analysis to detect changes in effector protein secretion
Membrane integrity and composition assessment
Evaluation of stress response and adaptation capabilities
Host Response Characterization:
Analysis of plant immune response markers
Reactive oxygen species production measurement
Callose deposition quantification
Defense gene expression profiling
Experimental Design Considerations:
This systematic approach allows for comprehensive characterization of XOO3615's role in pathogenicity while maintaining experimental efficiency through optimal design principles.
Studying the structure of membrane proteins like UPF0761 XOO3615 requires specialized approaches:
Computational Structure Prediction:
X-ray Crystallography Strategy:
Screen multiple constructs with variable N- and C-terminal boundaries
Test fusion proteins (e.g., T4 lysozyme) to enhance crystallization
Optimize detergent and lipid conditions for crystal formation
Consider lipidic cubic phase crystallization for membrane proteins
Cryo-EM Approach:
Optimize sample preparation (detergent selection, concentration)
Consider protein size limitations (potential for Fab fragment complexation)
Implement vitrification condition screening
Apply image processing strategies optimized for membrane proteins
NMR Spectroscopy Methods:
Selective isotope labeling of specific domains
Solid-state NMR approaches for membrane-embedded regions
Solution NMR for soluble domains
Dynamics measurements to identify flexible regions
Integrative Structural Biology:
Combine low-resolution techniques (SAXS, cryo-EM) with high-resolution methods
Use crosslinking mass spectrometry to provide distance constraints
Validate structural models with functional data
Apply membrane topology data to constrain model building
Structure Validation Framework:
| Method | Resolution Range | Advantages | Limitations |
|---|---|---|---|
| X-ray crystallography | 1.5-3.5 Å | High resolution | Crystallization challenges |
| Cryo-EM | 2.5-4.5 Å | No crystallization needed | Size limitations |
| NMR | Site-specific | Dynamic information | Size constraints |
| Computational prediction | Model-dependent | No experimental setup | Requires validation |
This multi-method approach provides complementary structural information, increasing confidence in the final structural model of UPF0761 membrane protein XOO3615.
Assessing potential transport function of membrane proteins like UPF0761 XOO3615 requires specialized experimental approaches:
Reconstitution Systems Development:
Proteoliposome preparation with controlled protein orientation
Giant unilamellar vesicle (GUV) formation for single-vesicle studies
Planar lipid bilayer reconstitution for electrophysiology
Optimization of lipid composition to match native environment
Transport Assay Design Matrix:
| Assay Type | Measurement Method | Advantages | Limitations |
|---|---|---|---|
| Flux assays | Fluorescence, radioactivity | Direct measurement | Limited to specific substrates |
| Counterflow | Isotope exchange | Sensitive detection | Requires substrate knowledge |
| Patch-clamp | Electrophysiology | Real-time kinetics | Technical complexity |
| FRET sensors | Fluorescence microscopy | Spatial resolution | Requires sensor development |
Substrate Screening Strategy:
Bioinformatic prediction of potential substrates
Development of high-throughput screening approaches
Testing of substrate analogs to define specificity
Competition assays to identify inhibitors
Energetic Coupling Analysis:
Investigation of ion gradient dependence
ATP requirement assessment
Membrane potential dependence testing
Thermodynamic analysis of transport process
Kinetic Characterization Framework:
Determination of transport rates under varying conditions
Analysis of concentration-dependent kinetics
Inhibition studies to define mechanism
Temperature dependence for thermodynamic parameters
These approaches should be implemented using optimal experimental design principles to efficiently identify transport function and characterize its mechanistic details, following similar optimization strategies used in other membrane protein studies .
Developing antibodies against membrane proteins like UPF0761 XOO3615 presents unique challenges requiring specialized approaches:
Antigen Design Strategies:
Extramembrane domain approach: Focus on hydrophilic regions predicted to be exposed
Peptide-based approach: Use multiple peptides from different regions
Denatured protein approach: For detection in Western blots
Native conformation approach: Using purified protein in detergent micelles or nanodiscs
Immunization Protocol Optimization:
Selection of appropriate species based on protein conservation
Use of adjuvant formulations optimized for membrane proteins
Extended immunization schedules with careful monitoring
Multiple boosting strategies to enhance specificity
Screening and Validation Framework:
| Validation Method | Purpose | Success Criteria |
|---|---|---|
| ELISA | Initial screening | Signal:noise >10:1 |
| Western blot | Specificity confirmation | Single band at expected MW |
| Immunoprecipitation | Native protein recognition | Enrichment >5-fold |
| Immunofluorescence | Subcellular localization | Membrane staining pattern |
Common Challenges and Solutions:
Low immunogenicity: Use carrier proteins and optimized adjuvants
Cross-reactivity: Perform extensive validation against related proteins
Conformational epitopes: Maintain native structure during immunization
Accessibility issues: Target exposed regions based on topology predictions
Advanced Antibody Development Approaches:
Phage display for selection of specific binders
Recombinant antibody production for consistent supply
Nanobody development for improved membrane protein recognition
Antibody engineering to enhance specificity and affinity
This comprehensive approach addresses the specific challenges associated with generating antibodies against membrane proteins, increasing the likelihood of obtaining specific and useful reagents for XOO3615 research.
Studying membrane protein insertion mechanisms using UPF0761 membrane protein XOO3615 as a model can provide valuable insights into fundamental biological processes:
In Vitro Translation and Insertion Systems:
Insertion Pathway Identification:
Sequential Insertion Analysis:
Create translation intermediates of increasing length
Map interactions with insertion machinery at each stage
Develop a temporal model of insertion process
Compare with known insertion mechanisms of other membrane proteins
Structure-Function Relationship Studies:
Generate systematic mutations in transmembrane domains
Identify critical residues for proper membrane insertion
Correlate insertion efficiency with physiochemical properties
Develop predictive models for insertion signals
Integration with Computational Approaches:
Molecular dynamics simulations of insertion process
Free energy calculations for membrane partitioning
Comparison with other UPF0761 family members
Development of generalizable principles for membrane protein biogenesis
This research approach leverages insights from recent advances in understanding membrane protein insertion mechanisms, such as those derived from EMC studies , providing a framework to elucidate the biogenesis pathways for UPF0761 family proteins.